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ess: upadhyayd@pol.neSummary Pulmonary intravascular bronchoalveolar tumor (IVBAT) also recognized
as pulmonary epithelioid hemangioendothelioma, is a rare malignant vascular tumor
of unknown etiology. IVBAT is a tumor of multicentric origin and the lungs are rarely
involved, with only about 60 cases of pulmonary IVBAT described in the literature.
The prognosis is unpredictable, with life expectancy ranging from 1 to 15 years. We
report an unusual case of pulmonary IVBAT that recurred in the lung with metastasis
to the mediastinum.
& 2005 Elsevier Ltd. All rights reserved.Case presentation
In 1984, a 58-year-old woman first presented with
bilateral lung nodules for which a left lower lobe
resection was performed (Fig. 1a). Biopsy of the
lung nodule revealed epithelioid cells with largeElsevier Ltd. All rights reserv
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t (D. Upadhyay).clear intracytoplasmic vacuoles consistent with
pulmonary IVBAT (Fig. 1b). She was not offered
therapy. Serial chest radiographs demonstrated
regression of the lung nodules (Fig. 1c).
In 2004, she presented with right lateral costal
margin tenderness of 4 weeks duration that she first
noticed while working in her yard. She denied other
symptoms and never smoked. On examination, she
was in minimal distress due to pain. Her vital signs
were normal. She had no lymphadenopathy. She
had digital clubbing and tenderness along the right
costal margin. The lung exam revealed dullness toed.
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Figure 1 Pulmonary intravascular bronchoalveolar tumor at initial presentation. (a) Chest radiograph shows bilateral
lung infiltrated and a postoperative scar. (b) Pulmonary IVBAT lung biopsy from 1984 revealed epithelioid cells with
large clear intracytoplasmic vacuoles consistent with pulmonary IVBAT. (c) Chest radiograph shows complete resolution
of lung nodules.
T.-M. Chen et al.368percussion in the right infrascapular and lower
axillary region with inspiratory crackles. A radio-
graph and a computerized tomography (CT) of the
chest revealed a well-circumscribed homogenous
mass in the right upper-lobe, posterior segment
with mediastinal lymphadenopathy (Fig. 2a). A
positron emission tomography (PET) scan revealed
intense uptake of fluorine-18-deoxyglucose in the
mass and in the mediastinal lymph nodes. A
hypermetabolic area was also seen in her right
chest wall consistent with the location of her chest
pain. There was no uptake in her liver. A flexible
fiberoptic bronchoscopy with bronchoalveolar la-
vage and biopsy were non-diagnostic. Mediastino-
scopy with a right mediastinal lymph node biopsy
revealed pulmonary epithelioid hemangioendothe-
lioma. Histopathological evaluation of the mass
showed a collection of epithelioid cells with largeclear intracytoplasmic vacuoles (Fig. 2b). Immuno-
histochemically, the tumor cells were cytokeratin
negative (Fig. 2c) while positive for vascular
marker CD31 (Fig. 2d) confirming their endothelial
lineage. Further, a comparison of the mediastinal
biopsy with her previous lung biopsy demonstrated
striking similarities, both showing epithelioid cells
with large clear intracytoplasmic vacuoles which
confirmed the histologic diagnosis of pulmonary
IVBAT.Discussion
Pulmonary IVBAT was first described by Dail et al.
in 1975.1 The tumor was thought to be an
aggressive form of bronchoalveolar carcinoma with
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Figure 2 Pulmonary intravascular bronchoalveolar tumor at current presentation. (a) Chest CT demonstrates the right
upper lobe posterior segment mass. (b) Mediastinal lymph node biopsy showing the epithelioid type cells with large
clear intracytoplasmic vacuoles. (c) The lymph node biopsy showing epithelioid cells negative for cytokeratin stains. (d)
The lymph node biopsy showing epithelioid cells with positive CD31 staining.
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Immunohistochemistry and electron microscopic
studies demonstrated that IVBAT is of endothelial
origin and the tumor was renamed epithelioid
hemangioendothelioma.2–4 IVBAT is a rare vascular
tumor of low-grade malignancy, although cases of
more aggressive behavior have been reported.5,6
IVBAT is a tumor of multicentric origin that can
arise from liver, bone, soft tissues and skin
simultaneously or sequentially.5,7–9 However, the
lungs are rarely involved. The incidence of pul-
monary tumor is slightly higher in women with a
male to female ratio of 1:1.6–4.5 The mean age at
diagnosis is 35 and life expectancy ranges between
1 and 20 years.5 IVBAT is often diagnosed inciden-
tally, as patients are usually asymptomatic or have
minor symptoms at the time of diagnosis.5,7
Histologic features of IVBAT include clusters of
spindled epithelioid cells with large, irregular
nuclei and nucleoli with a moderate amount of
vacuolated cytoplasm.5,10 Special immunohisto-chemical stains positive for endothelial cell mar-
kers such as CD31, CD34, factor VIII-related
antigen, and CD1A, and negative for cytokeratin,
support the diagnosis of IVBAT.5,10 Because of the
rarity of these tumors, little is known about the
treatment and prognosis. There is no single
effective treatment. Reports show that some
patients respond to chemotherapy with cyclopho-
sphamide plus cisplatin or carboplatin plus etopo-
side while others demonstrate a partial to near
complete response to interferon therapy.5,7–9 The
prognosis is very unpredictable. Spontaneous re-
gression of the tumor has been observed for up to
15 years after initial diagnosis.1,5 Extensive spread
to the intravascular, endobronchial or pleural
regions as well as the presence of liver nodules
and peripheral lymphadenopathy may predict a
worse prognosis.5,7–9 The life expectancy varies
from 1 to 15 years.1,5
In this case, recurrence of pulmonary IVBAT
occurred after 20 asymptomatic years. Our patient
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lung nodules at both presentations. The current
presentation appears to be more aggressive be-
cause of involvement of the lung, mediastinal
nodes and chest wall. She was advised palliative
radiation therapy to her chest wall followed
by combination chemotherapy with carboplatin
and etoposide. Although, pulmonary epithelioid
hemangioendothelioma is sometimes thought to
be derived from malignant epithelioid heman-
gioendothelioma of the liver; in our case, lack of
hypermetabolic uptake in her liver on PET scan
suggests that it is less likely to be derived from
the liver.Conclusion
In this case of pulmonary IVBAT, we observed
recurrence of the disease with an aggressive
presentation involving the mediastinum following
a prolonged period of remission.References
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